Not Yet Recruiting
A Study of DAT-2645 in Patients With BRCA1/2 Mutations or HRD-Positive Ovarian Cancer
NCT07652073
- Conditions
- Adnexal Diseases, Advanced or Metastatic Ovarian Cancer, Endocrine Gland Neoplasms, +13 more
- Locations
-
- Research site Guangzhou, Guangdong, China
- Research site Beijing, China